Serotonin selectivity for obsessive compulsive and panic disorders.
Montgomery
S A
SA
Academic Department of Psychiatry, St. Mary's Hospital, London, England.
Bullock
T
T
Fineberg
N
N
D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects*; D003866:Depressive Disorder / Q000188:drug therapy / Q000523:psychology; D016666:Fluvoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D016584:Panic Disorder / Q000188:drug therapy* / Q000523:psychology; D011985:Receptors, Serotonin / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000009:adverse effects / Q000627:therapeutic use*
D000928:Antidepressive Agents; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D016666:Fluvoxamine